OncoHRD ® (Tissue biopsy) A Next Generation Assistive HRD Test
فحص نقص إعادة التركيب المتماثل (HRD) بالخزعة النسيجية
Sample Type
🧪 Tissue
Results In
⏱ 15-20 Days
Fasting
✅ Not Required
Parameters
📊 1
What is OncoHRD ® (Tissue biopsy) A Next Generation Assistive HRD Test?
This tissue biopsy test assesses Homologous Recombination Deficiency (HRD), a genetic signature in cancer cells that indicates a weakness in their DNA repair pathways. Understanding HRD status is crucial for selecting specific targeted therapies.
Why is this test important?
Identifying HRD is clinically significant for patients with certain cancers, as it can predict responsiveness to specific treatments like PARP inhibitors. This information empowers oncologists to tailor treatment strategies for better patient outcomes.
How to Prepare
This test requires a tissue sample, typically obtained during a biopsy procedure. Your healthcare provider will give you specific instructions regarding the biopsy.
Frequently Asked Questions
Do I need to fast before my blood test?▼
Related Tests
Medical Disclaimer: The information on this page is for educational purposes only and should not be considered medical advice. Always consult your physician or qualified healthcare provider for diagnosis and treatment. Test results should be interpreted by a qualified medical professional.